|
Market Research Report
|
Genetic Engineering published by Global Industry Analysts, Inc. in October, 2009. This report consists of Pages: 63 and the price starts from US $ 950.
Abstract
The global outlook series on Genetic Engineering provides a collection of
market briefs and concise summaries of research findings. The report offers a
bird' s eye view of the industry, highlights latest developments, and discusses
demand drivers, issues and concerns, and regulatory environment. Discussion on
the industry' s most noteworthy regional market, the US, is amply detailed with
unbiased research commentary to provide the reader a rudimentary understanding
of the prevailing market climate. The report also provides select data on
regional markets. Also included is an indexed, easy-to-refer, fact-finder
directory listing the addresses, and contact details of 169 companies active
in the market.
Table of Contents
1. INDUSTRY OVERVIEW
- Genetic Engineering: A Prelude
- The Evolution and Progress of GM Crops
- GM Crops Gain Global Acceptance
- GM Cultivation Gains Prominence in Developing Nations
- Rising Prices, Food Shortage Make Biotech Grains Attractive
- Challenges to GM Crops Adoption
- Biotech Regulatory Measures Hinder Crop Domestication
- Governments Not to Give Up on GM Hope
- US - The Largest Producer of GM Crops
- Major Market Participants
2. MARKET DYNAMICS
- Global Food Demand to Drive Need for GM Crops
- Genetic Engineering - A Solution for Food Crisis!
- Harmful or Healthy: Breaking The Myth About GM Crops
- Non-food Sectors to Benefit from GE Technology
- Genetic Engineering and Enzymes
- GE to Help Starch and Sugar Processing Enzyme Market
- GE to Drive Demand for Bakery Enzymes
3. ISSUES AND CONCERNS
- The GM Food Issue Continues
- Nations at Crossroads to Accept or Object GE Crops
- Nations Set Global Agenda to Settle GM Crop Controversies
4. REGIONAL TRENDS
- US Soybean and Corn Crop to Witness Robust Growth
- GMO Crops' Future Hinges on Co-Existence Measures in EU
- UK Government' s GM Crops Proposal Faces Rebuff
- Spanish Transgenic Corn Plantation Increases
- Chinese Biopharmaceutical Market to Continue its Growth Spurt
- Government to Support Biopharmaceutical Innovation
- India - The Leading Cultivator of Bt Cotton
- India Ousts China in Bt Cotton Cultivation
- GM Crops to Earn Good Returns for Australia
- Biotechnology - A Boon for Agriculture in Malaysia
- Biotech Crops Cultivation Zooms in South Africa
5. GENETIC ENGINEERING: AN OVERVIEW
- The Concept...
- Molecular Basics - The Gene
- Genome - The Information Pool
- Evolution of Genetic Engineering
- Historical Developments in Genetic Engineering:
- The Human Genome Project
- Significant Events in the Past
- Gene Therapy
- Types of Gene Therapy
- Monogenic Gene Therapy
- Suicide Gene Therapy
- Antisense Gene Therapy
- Human Genetic Engineering
- Genetic Engineering in Animals
- Role of Biotechnology in Agriculture
- Insect Resistant Crops Vs. Herbicide Tolerant Crops
- Genetically Modified Foods
- GM Food Faces Worldwide Criticism During Initial Years
- Benefits of Genetically Modified Foods
- Pest Resistance
- Cold Tolerance
- Herbicide Tolerance
- Drought and Salinity Tolerance
- Disease Resistance
- Phytoremediation
- Nutrition
- Pharmaceuticals
- Negative Impacts of GM Foods
- Possibility of Crosspollination
- Decreased Pesticides Effectiveness
- Unintentional Destruction of Other Species
- Health Concerns Related to GM Foods
- Cost Concerns Related to GM Foods
- Genetic Engineering and Food Processing
- Genetic Engineering and Regulatory Environment
- Patents - An Overview
6. GENE THERAPY - A REVIEW
- Factors Influencing Gene Therapy' s Future Development
- Human Genome Analysis
- Gene Therapy - The Next Generation Cardiovascular Therapy
- Public Support for Gene Therapy
- RNAi Bode Bright Prospects
- Factors Hampering Gene Therapy FutureDevelopment
- Stringent US and European Regulatory Laws Prolongs Gene Therapy Development
- Identifying Genetic Fault
- Immune Response
- Delivering Genetic Materials into Patient Cells
- Multigene Disorders
- Side Effects
- Push Towards Germline Gene Transfer
- Technical Limitations
- Commercialization: A Road Uphill
- Time Line in Gene Therapy Drug Development
- Table 1: Gene Therapy Clinical Trials (2007): Percentage Breakdown by Geographic Region for the US, Europe, Canada, Japan and Rest of World
- Table 2: Gene Therapy Clinical Trials Worldwide (2007): A Split by Development Phase
- Various Gene Therapy Products Under Development (2007)
- Target Diseases and Players Involved
- Key Players by Application Area
- Table 3: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Disease/ Application Area for Cancer, Heart Disease, Monogenic Diseases, Infectious Diseases and Others
- Table 4: Gene Therapy Clinical Trials Worldwide (2007):Percentage Breakdown by Gene Type Transferred for Antigen, Cytokine, Tumor Suppressor, Growth Factor, Suicide, Deficiency and Others
- Table 5: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Vector Type for Adenovirus, Retrovirus, Naked/Plasmid DNA, Lipofection, Vaccinia Virus, Poxvirus, Adeno- associated Virus, and Others
- Gene Therapy Industry in Europe and the US - A Comparison
7. RESEARCH AND DEVELOPMENT
- Anti-Clotting Drug from GE Goats to Win Approval
- British Midlands University to Reveal Genetic Code of Bacterium Causing
- Hospital Acquired Infection
- Genetically Engineered BMPs to Facilitate Bone Formation in Orthopedic
Surgeries
- GE Finds Application in Obesity Control
- Trubion Develops Advanced mAbs
- New Study Reveals microRNA' s Role in Heart Failure
- Cell-based Assays to Aid in Early Drug Discovery
- Inhibition of SHIP Gene to Minimize Risk in Stem Cell Transplants
- Drug Discovery to Employ Chemical Genetics
- GE to Aid in the Discovery of New Enzyme Sources
- Demand for Lactose-Free Products Boosts Enzymes Applications Market
8. MERGERS & ACQUISITIONS
- RJH Industries Acquires Philippines Royal Oil
- Monsanto Takes Over Aly Participacoes
- Monsanto Acquires De Ruiter Seeds Group
- Lydall Announces Acquisition of DSM Solutech
- Biotie Completes Acquisition of elbion
- Pfizer Animal Health Acquires Catapult Genetics
- Monsanto Completes Marmot Acquisition
- BioEnergy Takes Over Assets of OmniGene Bioproducts
- BRAIN Takes Over Industrial Biotech Assets of MerLion Pharmaceuticals
- MTS Health Investors Acquires DNA Diagnostic Center
- Bayer HealthCare Takes Over Direvo Biotech
- QIAGEN Completes Acquisition of Corbett Life Science
- ChemVentures to Acquire BioFocus DPI Chemistry Facility
- Nanobac Pharmaceuticals to Take Over DNAPrint Genomics
- GlaxoSmithKline to Take Over Genelabs Technologies
- Invitrogen Merges with Applied Biosystems
- NitroMed Enters into Definitive Merger Agreement with Archemix
- Monsanto Completes Acquisition of Delta & Pine Land
- Inverness Medical Innovations Acquires Biosite
- Avesta Biotherapeutics Takes Over Siegfried Biologics
- Entelos Takes Over Iconix Biosciences
- Illumina Takes Over Solexa
- Celera Group Acquires Atria Genetics
- CytoDyn Acquires Advanced Genetic Technologies
- Takeda Europe to Take Over Paradigm Therapeutics
- AmerisourceBergen Announces Acquisition of IgG of America
- GlaxoSmithKline Plans Praecis Acquisition
9. RECENT INDUSTRY ACTIVITY
- Eureka, Glycos Partner to Develop Bacterium for Biorefinery
- Genzyme Acquires Rights to MabCampath, Fludara and Leukine
- Quantel Announces Genetic Engineering Technology Support for Lasergraphics
- USDA to Deregulate Syngenta' s GE Corn
- Archer Daniels, Deere & Company and Monsanto to Form Partnership
- Genzyme Collaborates with ICGEB
- Veredus Partners with STMicroelectronics to Establish Bio-Application Lab
- Invitrogen Gains License for Stem Cell Line
- Millipore Enters into Agreement with Solabia
- Advanced Cell Forms Joint Venture with CHA Biotech
- Luminex Enters into Agreement with Mingyuan
- ProGenTech Inks Agreement with Human Genetic Signatures
- Monsanto and China National Seed Group Sign Agreement
- Monsanto and Syngenta Sign Royalty-Bearing Licensing Agreement
- Affymetrix Signs Definitive Agreement with Panomics
- Sanofi-Aventis to Use Regeneron' s Genetic Modification Method
- Monsanto to Build DEKALB Corn Seed Production Facility
- Qatar Receives Grant to Augment Agro-Genetic Engineering Capacity
- Monsanto Expands Jerseyville Facility
- Sirtris Pharmaceuticals Obtains Approval for NamPRT
- Origin Agritech Obtains License for Phytase Corn
- Shenyang Xiehe Establishes Genetic Engineering Subsidiary
- BioServe Enters into Alliance with DNAPrint Genomics
- Evogene Teams Up with Ormat on Biodiesel
- EMD and Dendritic Nanotechnologies Enter into License and Supply Agreement
- AureoGen Biosciences Enters into Agreement with Takara Bio
- Shanghai Wanxing Inks Agreement with Blue Blood Biotech
- Stem Cell Sciences Signs Agreement with RIKEN Centre
- Olympus and National Center for Biological Sciences Open New Facility
- Biocentury Obtains Approval for Hybrid Cotton Seed in India
- Novozymes to Expand Operation Base
- Cell Therapeutics to Develop More Targeted Treatments for Cancer
10. PRODUCT/SERVICE LAUNCHES
- Affymetrix Introduces MyGeneChip Program
- Genomnz to Unveil DNA Testing Service
- Whatman Introduces EasiCollect
- Nanoxis Launches Membrane Protein
- Few Important Terms Used in Genetic Engineering
- Chromosomes
- Genome
- Recombinant DNA
- Retroviruses
- Plasmids
- Transgenic Animals and Plants
- Gene Therapy
GLOBAL DIRECTORY
|
